These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2739351)

  • 1. [Prophylaxis and treatment of osteoporosis].
    Kopera H
    Klin Wochenschr; 1989 May; 67(10):557-8. PubMed ID: 2739351
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 3. Anabolic steroids and osteoporosis.
    Dequeker J; Geusens P
    Acta Endocrinol Suppl (Copenh); 1985; 271():45-52. PubMed ID: 3865481
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
    Bone; 1989; 10(1):3-6. PubMed ID: 2736154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC; Moore SW; Whalen KE; Landy C
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C; Agnusdei D; Gonnelli S
    Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C; Macía ML; García J; Navarro JF
    Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgens, erythropoietin, iron stores, and lipoprotein (a) in hemodialysis patients.
    Fourtounas C; Tzanatos H; Fourtounas C; Kopelias I; Agroyannis B
    Am J Kidney Dis; 1997 Dec; 30(6):935-6. PubMed ID: 9398146
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ; Brocaar MP; Hakkesteegt MM; Birkenhäger JC
    Clin Otolaryngol Allied Sci; 1994 Feb; 19(1):79-84. PubMed ID: 8174308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C; Riis BJ; Pødenphant J; Christiansen C
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
    Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
    Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters.
    van Balkom RH; Dekhuijzen PN; van der Heijden HF; Folgering HT; Fransen JA; van Herwaarden CL
    Eur Respir J; 1999 May; 13(5):1062-9. PubMed ID: 10414405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
    Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.